CN102973744B - 一种用于混合型痔疮护理的外用药膏 - Google Patents
一种用于混合型痔疮护理的外用药膏 Download PDFInfo
- Publication number
- CN102973744B CN102973744B CN201310001032.9A CN201310001032A CN102973744B CN 102973744 B CN102973744 B CN 102973744B CN 201310001032 A CN201310001032 A CN 201310001032A CN 102973744 B CN102973744 B CN 102973744B
- Authority
- CN
- China
- Prior art keywords
- parts
- ointment
- radix
- rhizoma
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000014617 hemorrhoid Diseases 0.000 title claims abstract description 49
- 239000002674 ointment Substances 0.000 title claims abstract description 43
- 235000012222 talc Nutrition 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 229910052623 talc Inorganic materials 0.000 claims abstract description 10
- 239000000454 talc Substances 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims description 21
- 210000000582 semen Anatomy 0.000 claims description 18
- 244000024893 Amaranthus tricolor Species 0.000 claims description 17
- 235000014748 Amaranthus tricolor Nutrition 0.000 claims description 17
- 241000628997 Flos Species 0.000 claims description 17
- 230000000474 nursing effect Effects 0.000 claims description 14
- 239000004615 ingredient Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 241000206501 Actaea <angiosperm> Species 0.000 claims description 8
- 235000016993 Agrimonia Nutrition 0.000 claims description 8
- 241000207929 Scutellaria Species 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 6
- 238000001802 infusion Methods 0.000 claims description 6
- 235000011837 pasties Nutrition 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 239000003610 charcoal Substances 0.000 claims description 3
- 239000004570 mortar (masonry) Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 229940099259 vaseline Drugs 0.000 claims description 3
- 241001092084 Agrimonia Species 0.000 claims 4
- 239000008280 blood Substances 0.000 abstract description 50
- 210000004369 blood Anatomy 0.000 abstract description 49
- 230000000694 effects Effects 0.000 abstract description 20
- 208000002193 Pain Diseases 0.000 abstract description 11
- 230000036407 pain Effects 0.000 abstract description 11
- 230000008961 swelling Effects 0.000 abstract description 7
- 244000307697 Agrimonia eupatoria Species 0.000 abstract description 5
- 230000000740 bleeding effect Effects 0.000 abstract description 5
- 238000001816 cooling Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 238000012795 verification Methods 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 240000001592 Amaranthus caudatus Species 0.000 abstract 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000596154 Belamcanda Species 0.000 abstract 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 240000002045 Guettarda speciosa Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 244000173853 Sanguisorba officinalis Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 235000012735 amaranth Nutrition 0.000 abstract 1
- 239000004178 amaranth Substances 0.000 abstract 1
- 235000000125 common agrimony Nutrition 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 26
- 231100000614 poison Toxicity 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 16
- 208000001848 dysentery Diseases 0.000 description 14
- 206010007247 Carbuncle Diseases 0.000 description 12
- 230000000844 anti-bacterial effect Effects 0.000 description 11
- 210000002429 large intestine Anatomy 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 239000003440 toxic substance Substances 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000035861 hematochezia Diseases 0.000 description 8
- 206010010774 Constipation Diseases 0.000 description 7
- 201000004624 Dermatitis Diseases 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 208000010668 atopic eczema Diseases 0.000 description 7
- 238000012790 confirmation Methods 0.000 description 7
- 230000023597 hemostasis Effects 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 208000001780 epistaxis Diseases 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 201000007772 internal hemorrhoid Diseases 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 210000003932 urinary bladder Anatomy 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 208000034158 bleeding Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 208000006750 hematuria Diseases 0.000 description 4
- 230000002980 postoperative effect Effects 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010041660 Splenomegaly Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010061628 Anal infection Diseases 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- MAYJEFRPIKEYBL-OASIGRBWSA-N Obacunone Chemical compound C=1([C@@H]2OC(=O)[C@H]3O[C@@]43[C@]3(C)C(=O)C[C@H]5C(C)(C)OC(=O)C=C[C@]5(C)[C@H]3CC[C@]42C)C=COC=1 MAYJEFRPIKEYBL-OASIGRBWSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002561 chemical irritant Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- VSLDMVSILHVDSR-UHFFFAOYSA-N obacunone Natural products CC1(C)OC(=O)C=CC2(C)C1CC(=O)C3(C)C2CCC4(C)C(OC(=O)C5OC345)c6occc6 VSLDMVSILHVDSR-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002423 protozoacide Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种用于混合型痔疮护理的外用药膏,属中药领域。本发明药膏有效成分的原料组成及重量份数为:生地65~85份、苋菜60~80份、当归55~75份、蒲公英50~70份、地榆45~65份、黄芩40~60份、射干35~55份、五倍子35~50份、槐花30~45份、升麻30~40份、桃仁25~40份、仙鹤草20~35份、黄柏15~30份、黄连10~25份、滑石5~20份、煅牡蛎5~15份。本发明精选清热解毒、除湿消肿、凉血散瘀、润肠通便的中药材组方炮制,有软坚散结、止血定痛、清肠逐痔之功效,使用方便,吸收效果好,无不良及毒副作用,经临床验证,对内痔、外痔、混合痔都有极好的缓解及治疗效果,适于痔疮临床治疗与护理推广应用。
Description
所属技术领域
本发明涉及中药领域,尤其涉及一种用于混合型痔疮护理的外用药膏。
背景技术
痔疮是肛门直肠底部及肛门粘膜的静脉丛发生曲张而形成的一个或多个柔软的静脉团的一种慢性疾病,包括内痔、外痔、混合痔,是最常见的肛肠疾病。任何年龄都可发病,但随着年龄增长,发病率增高,通常当排便时持续用力,造成此处静脉内压力反复升高,静脉就会肿大,妇女在妊娠期,由于盆腔受压迫,阻碍血液循环时常会发生痔疮,许多肥胖的人也会罹患痔疮。
痔疮久拖不治,可以造成痔核脱出形成嵌顿,加重疼痛和病情,其次肛门感染,一旦形成痔疮出血症状,细菌、毒素、脓栓极易侵入血液引发脓毒败血症等。此外由于痔块脱出导致括约肌松弛,黏液流出肛门外长期刺激周围皮肤,易导致瘙痒及皮肤湿疹。痔疮的主要危害有贫血、嵌顿、坏死和感染,严重影响患者日常生活。许多痔疮患者认为药物能够治疗痔疮,于是盲目的涂抹各种药物,可是久治久不愈,而且越治越重,导致疼痛加剧,对此痔疮,患者切忌盲目用药治疗,不能一味的用药物,即便有效果,长期都会产生依赖性,最好办法是靠患者自身的调节,从生活中做起首先改变自身的生活习惯。对于痔疮的一般治疗方法,只有通过手术才能痊愈,盲目的药物治疗和其他疗法不能清除痔疮,通常药物可用于缓解或痔疮切除术前术后的护理。
传统中医理论认为,痔疮多是因风湿燥热侵袭脏、阴阳失调,气血纵横,经脉交错,浊气瘀血下注,湿热内生,气血运行不畅,经络阻滞,中焦湿热下注,血热毒火内盛等原因引发,对症下药时,当以具有清热解毒、除湿消肿、凉血散瘀、润肠通便、软坚散结、止血定痛、清肠逐痔功能的药材进行组方,从而促进局部血液循环,改善肛周及直肠末端微环境,促进肿块消失,治愈痔疮。目前常见的痔疮用药多以口服,可能对痔疮有一定的疗效,但明显不适合痔疮术后护理。
发明内容
本发明提供了一种用于混合型痔疮护理的外用药膏,具有清热解毒、除湿消肿、凉血散瘀、润肠通便、软坚散结、止血定痛、清肠逐痔之功效,治病求源标本兼治,对内痔、外痔、混合痔均具有很好的护理效果。
为实现上述目的,本发明的技术方案实施如下:
一种用于混合型痔疮护理的外用药膏,制成所述药膏有效成分的原料组成及重量份数为:
生地65~85份 苋菜60~80份 当归55~75份 蒲公英50~70份
地榆45~65份 黄芩40~60份 射干35~55份 五倍子35~50份
槐花30~45份 升麻30~40份 桃仁25~40份 仙鹤草20~35份
黄柏15~30份 黄连10~25份 滑石5~20份 煅牡蛎5~15份。
制成所述药膏有效成分的原料组成及重量份数为:
生地70~80份 苋菜65~75份 当归60~70份 蒲公英55~65份
地榆50~60份 黄芩45~55份 射干40~50份 五倍子38~46份
槐花32~42份 升麻32~38份 桃仁28~36份 仙鹤草22~32份
黄柏18~28份 黄连12~22份 滑石7~15份 煅牡蛎6~12份。
制成所述药膏有效成分的原料组成及重量份数为:
生地73~78份 苋菜68~72份 当归63~67份 蒲公英58~62份
地榆53~57份 黄芩47~53份 射干42~47份 五倍子40~44份
槐花34~40份 升麻34~36份 桃仁30~34份 仙鹤草24~28份
黄柏20~26份 黄连14~18份 滑石9~13份 煅牡蛎8~10份。
制成所述药膏有效成分的原料组成及重量份数为:
生地74份 苋菜70份 当归65份 蒲公英60份
地榆54份 黄芩48份 射干44份 五倍子42份
槐花36份 升麻35份 桃仁32份 仙鹤草26份
黄柏22份 黄连16份 滑石10份 煅牡蛎9份。
一种用于混合型痔疮护理的外用药膏的制备方法,包括以下工艺步骤:
(1)将黄芩、射干、五倍子、滑石、煅牡蛎混合后粉碎,研末,过200目细粉,备用。
(2)将升麻用武火翻炒数次后,表面均匀喷洒黄酒,炒干后粉碎,研末,过200目细粉,备用。
(3)将地榆用武火烤炙为炭,粉碎后研末,过200目细粉,备用。
(4)将生地、苋菜、蒲公英、槐花、桃仁放入研钵中,反复碾压至成糊状药膏,去除杂质,备用。
(5)将当归、仙鹤草、黄柏、黄连放入容器中,加入五倍量的水,用武火熬煮,剩余一倍量的水后,再加入五倍量的水,继续用武火熬煮至成糊状药膏,去除杂质,备用。
(6)将步骤(1)、步骤(2)、步骤(3)所得的细粉,与步骤(4)、步骤(5)制得的药膏混合,加入凡士林后,以现代科学工艺制备为外用软膏剂产品。
本发明所用中药的药性如下:
生地:味甘;苦;性微寒。归心;肝;肾经。滋阴清热;凉血补血。主治热病烦渴;内热消渴;骨蒸劳热;温病发斑;血热所致的吐血;崩漏;尿血;便血;血虚萎黄;眩晕心悸;血少经闭。《日华子本草》载:“治惊悸劳劣,心肺损,吐血,鼻衄。”现代医学研究证实,生地是有效的免疫增强剂,包含对人体有好处的多类氨基酸、糖类,并且有强心、利尿、降压、降糖、保肝、抑菌、升高血细胞等药理作用。
苋菜:味甘;性微寒。入大肠;小肠经。清热解毒;通利二便。主治痢疾;二便不通;蛇虫螫伤;疮毒。《滇南本草》载:“治大小便不通,化虫去寒热,能通血脉,逐瘀血。”现代医学研究证实,苋菜提取物中的正烷烃类、正烷醇类、甾醇类对金黄色葡萄球菌、白色葡萄球菌、草绿色链球菌、大肠肝菌、绿脓假单胞菌和克雷白杆菌有较强的抗菌作用。
当归:味甘;辛;性温。归肝、心、脾经。补血活血;调经止痛;润肠通便。主治血虚萎黄;眩晕心悸;虚寒腹痛;风湿痹痛;痈疽疮疡。《本草正》载:“其味甘而重,故专能补血,其气轻而辛,故又能行血,能养营养血,补气生精,安五脏,强形体,益神志。”现代医学研究证实,当归具有抗菌、消炎作用。
蒲公英:味苦;甘;性寒。归肝;胃经。清热解毒;消痈散结。主治乳痈;肺痈;肠痈;痄腮;疔毒疮肿;目赤肿痛;感冒发热;咳嗽;咽喉肿痛;胃火;肠炎;痢疾;肝炎;胆囊炎;尿路感染。《滇南本草》载:“治诸疮肿毒,颓癣疮;祛风,消诸疮毒,散瘰疬结核;止小便血,治五淋癃闭,利膀胱。”临床医学研究表明,薄公英制剂在一定程度上可代替抗菌素使用,对某些疾病表现出广谱抗菌素的功效,有一定的抗病毒功能。
地榆:味苦;酸;性寒,无毒。入肝;肺;肾;大肠经。凉血止血;清热解毒;消肿敛疮。主治吐血;咯血;衄血;尿血;便血;痔血;血痢;崩漏;疮痈肿痛;湿疹;阴痒。《别录》载:“止脓血,诸痿,恶疮,消酒,除消渴,补绝伤,产后内塞,可作金疮膏,主内漏不止,血不足。”现代医学研究证实,地榆含有大量鞣质,有较强的收敛性,能收缩血管,降低血管的通透性,减少炎性渗出,同时还有明显的杀菌作用,能对抗绿脓杆菌感染。
黄芩:味苦;性寒。归肺;胆;脾;胃;大肠;小肠经。清热燥湿;泻火解毒;止血安胎;降血压。主治湿温、胸闷呕恶;湿热痞满;泻痢;黄疸;肺热咳嗽;血热吐衄;痈肿疮毒。《本经》载:“主诸热黄疸,肠僻,泄利,逐水,下血闭,恶疮,疽蚀,火疡。”现代医学研究证实,黄芩有显著的抑菌、抗真菌、抗病毒、抗炎、抗变态反应等作用,能降低血压、抑制血小板聚集、抗凝、降血脂,此外还有保肝、利胆、抗氧化、抗癌功效。
射干:味苦;性寒;有毒。入肺;肝经。降火;解毒;散血;消痰。主治喉痹咽痛;咳逆上气;痰涎壅盛;瘰疬结核;疟母;妇女经闭;痈肿疮毒。《滇南本草》载:“治咽喉肿痛,咽闭喉风,乳蛾,痄肋红肿,牙根肿烂,攻散疮痈一切热毒等症。”现代医学研究证实,射干对外感及咽喉疾患中的某些病毒有抑制和延缓作用,抗病原微生物,对抗透明质酸酶,抑制芽囊的炎性渗出和炎性增生。
五倍子:味酸;涩;性寒。入肺;胃;大肠;肝;肾经。敛肺;止汗;涩肠;固精;止血;解毒。主治肺虚久咳;久痢久泻;脱肛;遗精;白浊;各种出血;痈肿疮疖。《纲目》载:“敛肺降火,化痰饮,止咳嗽,消渴,盗汗,呕吐,失血,久痢,黄病,心腹痛,小儿夜啼,治眼赤湿烂,消肿毒、喉痹,敛溃疮、金疮,收脱肛、子肠坠下。”现代医学研究证实,五倍子所含的鞣酸对蛋白质有沉淀作用,收缩小血管,对多种致病菌有明显的抑菌或杀菌作用,能与重金属离子、生物碱及甙类形成不溶性复合物剂。
槐花:味苦;性微寒。入肝;肺;心;大肠经。凉血止血;清肝明目。主治肠风便血;痔疮下血;血痢;尿血;血淋;崩漏;吐血;衄血;肝热头痛;目赤肿痛;痈肿疮疡。《本草正》载:“凉大肠,杀疳虫。治痈疽疮毒,阴疮湿痒,痔漏,解杨梅恶疮,下疳伏毒。”现代医学研究证实,槐花所含的芸香甙可增强毛细血管抵抗力,改善血管壁脆性,降低血压、抗水肿,对高血压有防止脑血管破裂的功效,此外还有抗炎作用。
升麻:味辛;甘;性微寒。归肺;脾;大肠;胃经。清热解毒;发表透疹;升阳举陷。主治时疫火毒;口疮;咽痛;斑疹;头痛寒热;痈肿疮毒;中气下陷;脾虚泄泻;久痢下重。《纲目》载:“升麻引阳明清气上行,柴胡引少阳清气上行,此乃禀赋素弱、元气虚馁及劳役饥饱、生冷内伤,脾胃引经最要药也。”现代医学研究证实,升麻提取物具有抗菌、降压、抑制心肌、减慢心率的作用,对中枢神经系统有镇静作用。
桃仁:味苦;甘;性平。归心;肝;大肠经。活血祛瘀;润肠通便;止咳平喘。主治经闭;痛经;癓瘕痞块;跌扑损伤;肠燥便秘。《本经逢原》载:“桃仁,为血瘀血闭之专药。苦以泄滞血,甘以生新血,治热入血室,瘀积症瘕,疟母,心腹痛,亦散肝经之血结。”现代医学研究证实,桃仁醇提液可增加静脉血管流量,舒张血管,能增加股动脉血流量,降低血管阻力,对血管壁有直接扩张作用,此外还有抑制血液凝固和溶血作用。
仙鹤草:味苦;涩;性平。入肺;肝;脾经。收敛止血;止痢;杀虫。主治咯血;吐血;尿血;便血;赤白痢疾;崩漏带下;劳伤脱力;痈肿;跌打;创伤出血。《百草镜》载:“下气活血,理百病,散痞满;跌扑吐血,血崩,痢,肠风下血。”现代医学研究证实,仙鹤草为强壮性收敛止血药,抑制纤维蛋白溶酶的活性,有强心、升血压、凝血、止血、凉血、抗菌等作用。
黄柏:味苦;性寒。入肾;膀胱经。清热燥湿;泻火解毒。主治湿热痢疾、泄泻、黄疸;梦遗、淋浊、带下;骨蒸劳热;以及口舌生疮;目赤肿痛;痈疽疮毒;皮肤湿疹。《药品化义》载:“降火能自顶至踵,沦肤彻髓,无不周到,专泻肾与膀胱之火。”现代医学研究证实,黄柏含小蘖碱、黄柏酮等主要成分,有抗菌、收敛、消炎的作用,对各种皮肤湿毒、疮疡等症状,功效良好。
黄莲:味苦;性寒。归心;脾;胃;肝;胆;大肠经。清热燥湿;泻火争毒。用于湿热痞满,呕吐吞酸;泻痢;黄疸;高热神昏;心火亢盛;心烦不寐;血热吐衄;目赤;牙痛;消渴;痈肿疔疮;外治湿疹;湿疮;耳道流脓。现代医学研究证明,黄连有较强的抗微生物及抗原虫作用,可降低血溏,抗血小板聚集及溶栓,此外对鼻咽癌和宫颈癌也有抑制作用。
滑石:味甘;淡;性寒;无毒。入胃;膀胱经。利水通淋;清热解暑;收湿敛疮;主治膀胱湿热;暑热烦渴;小便不利;泄泻;尿淋涩痛;湿疹;湿疮;水肿;衄血。《本草衍义补遗》载:“燥湿,分水道,实大肠,化食毒,行积滞,逐凝血,解燥渴,补脾胃,降心火。”现代医学研究表明,滑石对伤寒杆菌、副伤寒甲杆菌、脑膜炎球菌有抑制作用,外用能吸附大量的化学刺激物或毒物,可保护发炎或破损组织的表面,内服除保护发炎的胃肠粘膜而发挥镇吐、止泻作用外,还能阻止毒物在胃肠道中的吸收。
煅牡蛎:味咸;性微寒。入肝;肾经。平肝潜阳;重镇安神;软坚散结;收敛固涩。主治眩晕耳鸣;惊悸失眠;瘰疬瘿瘤;癓瘕痞块。《本草纲目》载:“化痰软坚,清热除湿,止心脾气痛,痢下,赤白浊,消疝瘕积块,瘿疾结核。”现代医学研究证实,煅牡蛎有收敛、镇静、解毒、镇痛的作用,酸性提取物对脊髓灰质炎病毒有抑制作用。
本发明与现有技术相比,具有以下有益效果:
本发明精选清热解毒、除湿消肿、凉血散瘀、润肠通便的中药材组方炮制,有软坚散结、止血定痛、清肠逐痔之功效,使用方便,吸收效果好,无不良及毒副作用,经临床验证,对内痔、外痔、混合痔都有极好的缓解及治疗效果,适于痔疮临床治疗与护理推广应用。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明药膏有效成分的原料组成及重量为:
生地80g 苋菜75g 当归70g 蒲公英65g
地榆60g 黄芩55g 射干50g 五倍子45g
槐花40g 升麻38g 桃仁35g 仙鹤草30g
黄柏28g 黄连20g 滑石15g 煅牡蛎13g。
本发明药膏制备方法的工艺步骤为:
(1)将黄芩、射干、五倍子、滑石、煅牡蛎混合后粉碎,研末,过200目细粉,备用。
(2)将升麻用武火翻炒数次后,表面均匀喷洒黄酒,炒干后粉碎,研末,过200目细粉,备用。
(3)将地榆用武火烤炙为炭,粉碎后研末,过200目细粉,备用。
(4)将生地、苋菜、蒲公英、槐花、桃仁放入研钵中,反复碾压至成糊状药膏,去除杂质,备用。
(5)将当归、仙鹤草、黄柏、黄连放入容器中,加入五倍量的水,用武火熬煮,剩余一倍量的水后,再加入五倍量的水,继续用武火熬煮至成糊状药膏,去除杂质,备用。
(6)将步骤(1)、步骤(2)、步骤(3)所得的细粉,与步骤(4)、步骤(5)制得的药膏混合,加入凡士林后,以现代科学工艺制备为外用软膏剂产品。
用法用量:每日3次,每次1.5~2ml,外痔患者均匀涂抹于肛周,内痔患者推注入肛门内2~3cm处,混合痔患者涂抹、推注并用。5天为一个疗程,通常1~3个疗程起效。
实施例2
本发明药膏有效成分的原料组成及重量为:
生地78g 苋菜73g 当归68g 蒲公英63g
地榆58g 黄芩53g 射干48g 五倍子44g
槐花39g 升麻36g 桃仁34g 仙鹤草29g
黄柏26g 黄连18g 滑石13g 煅牡蛎12g。
本实施例的药膏制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明药膏有效成分的原料组成及重量份数为:
生地76g 苋菜71g 当归66g 蒲公英62g
地榆55g 黄芩51g 射干45g 五倍子45g
槐花38g 升麻36g 桃仁33g 仙鹤草28g
黄柏24g 黄连17g 滑石12g 煅牡蛎10g。
本实施例的药膏制备方法工艺步骤及用法用量与实施例1相同。
实施例4
本发明药膏有效成分的原料组成及重量份数为:
生地74g 苋菜70g 当归65g 蒲公英60g
地榆54g 黄芩48g 射干44g 五倍子42g
槐花36g 升麻35g 桃仁32g 仙鹤草26g
黄柏22g 黄连16g 滑石10g 煅牡蛎9g。
本实施例的药膏制备方法工艺步骤及用法用量与实施例1相同。
临床资料:
经我院对80例肿痛、脱出、糜烂出血及渗出等症状表现的患者,分组对照进行痔疮切除术前术后护理进行跟踪观察,结果显示本发明所述外用药膏能明显缓解肿痛,收敛局部血管及神经,促进手术刀口愈合,完全适用于内痔、外痔、混合痔的日常护理及术后护理,宜于临床推广使用。
Claims (5)
1.一种用于混合型痔疮护理的外用药膏,其特征在于:制成所述药膏有效成分的原料组成及重量份数为:
生地65~85份 苋菜60~80份 当归55~75份 蒲公英50~70份
地榆45~65份 黄芩40~60份 射干35~55份 五倍子35~50份
槐花30~45份 升麻30~40份 桃仁25~40份 仙鹤草20~35份
黄柏15~30份 黄连10~25份 滑石5~20份 煅牡蛎5~15份。
2.根据权利要求1所述的一种用于混合型痔疮护理的外用药膏,其特征在于:制成所述药膏有效成分的原料组成及重量份数为:
生地70~80份 苋菜65~75份 当归60~70份 蒲公英55~65份
地榆50~60份 黄芩45~55份 射干40~50份 五倍子38~46份
槐花32~42份 升麻32~38份 桃仁28~36份 仙鹤草22~32份
黄柏18~28份 黄连12~22份 滑石7~15份 煅牡蛎6~12份。
3.根据权利要求1所述的一种用于混合型痔疮护理的外用药膏,其特征在于:制成所述药膏有效成分的原料组成及重量份数为:
生地73~78份 苋菜68~72份 当归63~67份 蒲公英58~62份
地榆53~57份 黄芩47~53份 射干42~47份 五倍子40~44份
槐花34~40份 升麻34~36份 桃仁30~34份 仙鹤草24~28份
黄柏20~26份 黄连14~18份 滑石9~13份 煅牡蛎8~10份。
4.根据权利要求1所述的一种用于混合型痔疮护理的外用药膏,其特征在于:制成所述药膏有效成分的原料组成及重量份数为:
生地74份 苋菜70份 当归65份 蒲公英60份
地榆54份 黄芩48份 射干44份 五倍子42份
槐花36份 升麻35份 桃仁32份 仙鹤草26份
黄柏22份 黄连16份 滑石10份 煅牡蛎9份。
5.一种如权利要求1-4任一项所述的用于混合型痔疮护理的外用药膏的制备方法,其特征在于:包括以下工艺步骤:
(1)将黄芩、射干、五倍子、滑石、煅牡蛎混合后粉碎,研末,过200目细粉,备用;
(2)将升麻用武火翻炒数次后,表面均匀喷洒黄酒,炒干后粉碎,研末,过200目细粉,备用;
(3)将地榆用武火烤炙为炭,粉碎后研末,过200目细粉,备用;
(4)将生地、苋菜、蒲公英、槐花、桃仁放入研钵中,反复碾压至成糊状药膏,去除杂质,备用;
(5)将当归、仙鹤草、黄柏、黄连放入容器中,加入五倍量的水,用武火熬煮,剩余一倍量的水后,再加入五倍量的水,继续用武火熬煮至成糊状药膏,去除杂质,备用;
(6)将步骤(1)、步骤(2)、步骤(3)所得的细粉,与步骤(4)、步骤(5)制得的药膏混合,加入凡士林后,以现代科学工艺制备为外用软膏剂产品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310001032.9A CN102973744B (zh) | 2013-01-01 | 2013-01-01 | 一种用于混合型痔疮护理的外用药膏 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310001032.9A CN102973744B (zh) | 2013-01-01 | 2013-01-01 | 一种用于混合型痔疮护理的外用药膏 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102973744A CN102973744A (zh) | 2013-03-20 |
| CN102973744B true CN102973744B (zh) | 2014-08-06 |
Family
ID=47848279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310001032.9A Expired - Fee Related CN102973744B (zh) | 2013-01-01 | 2013-01-01 | 一种用于混合型痔疮护理的外用药膏 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102973744B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105012533A (zh) * | 2015-08-24 | 2015-11-04 | 张德生 | 一种治疗痔疮的中药药剂 |
| CN105726808A (zh) * | 2016-03-25 | 2016-07-06 | 广西大学 | 一种治疗痔疮的膏药的制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102772711A (zh) * | 2012-08-21 | 2012-11-14 | 杨兰英 | 一种治疗痔疮的药物及其制备方法 |
-
2013
- 2013-01-01 CN CN201310001032.9A patent/CN102973744B/zh not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102772711A (zh) * | 2012-08-21 | 2012-11-14 | 杨兰英 | 一种治疗痔疮的药物及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102973744A (zh) | 2013-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102579918B (zh) | 治疗青光眼的中药组合物、制备方法及给药方式 | |
| CN103877455A (zh) | 一种治疗痤疮的中药组合物 | |
| CN104225138A (zh) | 一种通过内服外洗治疗褥疮的中药及其制备方法 | |
| CN103316146B (zh) | 一种麻醉用中药制剂 | |
| CN104689066A (zh) | 一种用于治疗烧伤的中药组合物及其制备方法 | |
| CN108186839A (zh) | 一种治疗盆腔炎的热敷剂及其热敷方法 | |
| CN103751691B (zh) | 一种治疗湿疹的药物 | |
| CN103520530B (zh) | 一种治疗丹毒的药物及其制备方法 | |
| CN104873851A (zh) | 一种内服、外用治疗褥疮的中药组合物 | |
| CN102973744B (zh) | 一种用于混合型痔疮护理的外用药膏 | |
| CN104161823B (zh) | 一种治疗股骨头无菌性坏死的中药 | |
| CN103007093A (zh) | 一种治疗妇科炎症的药物及其制备方法 | |
| CN102940831A (zh) | 一种用于抑菌与治疗妇科炎症的外用泡腾片 | |
| CN105288071A (zh) | 一种用于痔疮治疗及术后护理的中药组方及制备方法 | |
| CN104383384A (zh) | 一种治疗手足癣的中药洗液 | |
| CN103610772B (zh) | 治疗脑血栓的中药 | |
| CN104623304A (zh) | 一种治疗湿热毒蕴型慢性皮肤溃疡的洗剂及其制备方法 | |
| CN104189489A (zh) | 一种具有治疗慢性湿疹功效的药剂及其制备方法 | |
| CN104173973A (zh) | 一种治疗痢疾的口服液及其制备方法 | |
| CN103845547A (zh) | 用于治疗流行性腮腺炎的中药汤剂 | |
| CN103223151A (zh) | 一种增白祛斑的中药组合物及其制剂的制备方法 | |
| CN103285131B (zh) | 一种治疗乳腺炎的中药洗液 | |
| CN108186864A (zh) | 一种治疗痤疮的中药 | |
| CN101564510A (zh) | 一种有效治疗鹅掌风的中药擦剂 | |
| CN104107374A (zh) | 一种用于治疗宫颈糜烂的中药胶囊及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140806 Termination date: 20150101 |
|
| EXPY | Termination of patent right or utility model |